BOTOX ONE Trademark

Trademark Overview


On Tuesday, March 21, 2017, a trademark application was filed for BOTOX ONE with the United States Patent and Trademark Office. The USPTO has given the BOTOX ONE trademark a serial number of 87379786. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, October 18, 2024. This trademark is owned by Allergan, Inc.. The BOTOX ONE trademark is filed in the Advertising, Business and Retail Services and Insurance & Financial Services categories with the following description:

Providing reimbursement support for licensed healthcare professionals, namely, financial administration of patient reimbursement programs pertaining to therapeutic treatments in the field of neurology, dermatology, and urology

Providing reimbursement support for licensed healthcare professionals, namely, business administration of patient reimbursement programs pertaining to therapeutic treatments in the field of neurology, dermatology, and urology
botox one

General Information


Serial Number87379786
Word MarkBOTOX ONE
Filing DateTuesday, March 21, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, October 18, 2024
Registration Number5734450
Registration DateTuesday, April 23, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 4, 2017

Trademark Statements


Description of MarkThe mark consists of the words "BOTOX ONE" with three curved lines starting from a point within the middle of the letter "O" in "ONE" and ending above the letter "T".
Goods and ServicesProviding reimbursement support for licensed healthcare professionals, namely, financial administration of patient reimbursement programs pertaining to therapeutic treatments in the field of neurology, dermatology, and urology
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesProviding reimbursement support for licensed healthcare professionals, namely, business administration of patient reimbursement programs pertaining to therapeutic treatments in the field of neurology, dermatology, and urology

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateSaturday, May 6, 2017
Primary Code035
First Use Anywhere DateSaturday, January 19, 2019
First Use In Commerce DateSaturday, January 19, 2019

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, March 24, 2017
Primary Code036
First Use Anywhere DateSaturday, January 19, 2019
First Use In Commerce DateSaturday, January 19, 2019

Trademark Owner History


Party NameAllergan, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064

Party NameAllergan, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612

Party NameAllergan, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612

Trademark Events


Event DateEvent Description
Friday, April 28, 2017PRIORITY ACTION E-MAILED
Friday, April 28, 2017NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, May 5, 2017EXAMINERS AMENDMENT E-MAILED
Friday, March 24, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 25, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, April 27, 2017ASSIGNED TO EXAMINER
Friday, April 28, 2017PRIORITY ACTION WRITTEN
Friday, May 5, 2017EXAMINERS AMENDMENT -WRITTEN
Friday, May 5, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, May 5, 2017ASSIGNED TO LIE
Tuesday, February 20, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, February 20, 2018SOU EXTENSION 1 FILED
Tuesday, February 20, 2018SOU EXTENSION 1 GRANTED
Thursday, February 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 8, 2017EXAMINER'S AMENDMENT ENTERED
Monday, May 8, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 1, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 14, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 4, 2017PUBLISHED FOR OPPOSITION
Tuesday, July 4, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 29, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 26, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 12, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 24, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, July 24, 2018SOU EXTENSION 2 FILED
Tuesday, July 24, 2018SOU EXTENSION 2 GRANTED
Wednesday, February 20, 2019TEAS STATEMENT OF USE RECEIVED
Wednesday, February 20, 2019USE AMENDMENT FILED
Tuesday, March 12, 2019STATEMENT OF USE PROCESSING COMPLETE
Saturday, March 16, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 23, 2019REGISTERED-PRINCIPAL REGISTER
Friday, March 15, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 23, 2024TEAS SECTION 8 & 15 RECEIVED
Friday, October 18, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, October 18, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, October 18, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, April 23, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED